A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease

Clinical trial NCT01711333 · COMPLETED

Trial details

NCT number: NCT01711333
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Occlusive Arterial Disease

Start date: 2012-10-26
Primary completion: 2014-05-20
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.